StonvexLoading…
StonvexStonvexStonvexCore line items from CPRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 | Annual 2025 2025-03-29 |
|---|---|---|---|---|
Revenue | $2.68B | $1.65B | $797.00M | $4.44B |
Operating Income | $50.00M | $4.00M | $16.00M | $-752.00M |
Net Income | $141.00M | $25.00M | $53.00M | $-1.18B |
EPS (Diluted) | $1.18 | $0.22 | $0.44 | $-10.00 |
Total Assets | $3.33B | $5.62B | $5.47B | $5.21B |
Total Liabilities | $3.23B | $5.69B | $5.48B | $4.84B |
Cash & Equivalents | $154.00M | $120.00M | $129.00M | $107.00M |
Free Cash Flow OCF − CapEx | $97.00M | $-86.00M | $-21.00M | $153.00M |
Shares Outstanding | 119.15M | 119.07M | 119.04M | 117.91M |